Review highlights emerging igg4-related disease therapies and the need for optimal glucocorticoid-sparing options.
No takes yet. Share an insight, caveat, or question.
García et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: